Abstract
The antibacterial activities of RPR 106,972 and quinupristin/dalfopristin (RP 59,500) were determined by the broth microdilution susceptibility test method. No major differences were seen among MICs for 863 isolates representing 22 species. However, there were minor twofold differences in MICs for some species. On a weight-to-weight basis, the activities of the oral and parenteral streptogramins were essentially the same. Because the route of administration and the pharmacokinetics differ, it is not necessarily appropriate to extrapolate such in vitro observations to predict identical clinical and bacteriological response rates for the two drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Spangler SK, Jacobs MR, Appelbaum PC: Activities of RPR 106,972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and-resistant pneumococci. Antimicrobial Agents and Chemotherapy 1996, 40: 481–484.
Bouanchaud DH: In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500. Journal of Antimicrobial Chemotherapy 1992, 30 (Supplement A): 95–99.
Low DE: Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics and initial clinical experience. Microbial Drug Resistance 1995, 1: 223–234.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Wayne, PA, 1993.
Barry AL, Fuchs PC: In vitro activities of a streptogramin (RP 59,500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrobial Agents and Chemotherapy 1995, 32: 238–240.
Leclercq R, Nantas L, Soussy CJ, Duval J: Activity of RP 59,500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 67–75.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barry, A.L., Fuchs, P.C. & Brown, S.D. In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycin. Eur. J. Clin. Microbiol. Infect. Dis. 16, 155–158 (1997). https://doi.org/10.1007/BF01709476
Issue Date:
DOI: https://doi.org/10.1007/BF01709476